Nonprofit competition organizer XPrize is partnering with global tech consultancy Cognizant to award AI innovators in a pandemic response challenge.

Almost half the 540-participant cohort is already using at least one form of AI.

The novel coronavirus has shown a nasty penchant for targeting the kidneys, and physicians can’t always tell which patients will need dialysis until they do. By then it’s often too late to save a life.

Knowing that antibodies as well as viruses bind to certain proteins in certain ways, scientists have come up with a technique to watch both sickness-signaling materials stick to microscopic beads prepared for the purpose.

The COVID-19 pandemic is a bad dream in the truest sense of the word—and AI helps to prove it, a team of researchers assert in a study published online Oct. 1 in Frontiers in Psychology.

More than half of Americans, 54%, have seen doctors remotely during the COVID crisis. However, some 48% might not touch telehealth again if their data were to get hacked during a telehealth-related breach.

Machine learning is playing a key role in predicting all major forms of drug cardiotoxicity, potentially helping reduce late-stage clinical trial failures.

South Korean researchers are working on packing the ability to monitor heart health and detect signs of atrial fibrillation into what might be the smallest cardiology wearable to date: a “smart ring.”